 FORT COLLINS, Colo., Sept. 1, 2021 PRNewswire -- Statera BioPharma NASDAQ: STAB, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today provided an update on the integration of the ImQuest BioSciences business unit and the status of the post-merger stock conversion process. 